Private Infrastructure Investment Has Been Put to the Test in a Challenging Environment; the Number of Infrastructure Deals Declined by 18% in 2023, and Global Infrastructure Fundraising Fell by 50% from a High of $176 Billion in 2022 to $89 Billion Private Infrastructure Investment Will…
Month: March 2024
NEW YORK, March 17, 2024 /PRNewswire/ — The data center rack market size is forecast to increase by USD 1628.53 million from 2022 to 2027, at a CAGR of 11.25%. Technavio has extensively analyzed 15 major vendors, including Belden Inc., Black Box Corp., Chatsworth Products Inc., Cisco…
MONTREAL, March 17, 2024 /PRNewswire/ — Nuvei Corporation (NASDAQ: NVEI) (TSX: NVEI) (the “Company” or “Nuvei”) announces today that it is aware of recent media reports speculating as to a potential going-private transaction involving the Company. While the Company’s policy is to not…
Unflinching Exploration of Female Courage During Taiwan’s White Terror Period Now Available for Free for the First-Time Streaming Exclusively on TaiwanPlus TAIPEI, March 17, 2024 /PRNewswire/ — TaiwanPlus is honored to announce and share the first-ever online release of “Untold…
NEW YORK, March 17, 2024 /PRNewswire/ — The dairy alternatives market is set to grow by USD 18.49 billion from 2022 to 2027 progressing at a CAGR of 10.85% during the forecast period. Key companies include- Archer Daniels Midland Co., Blue Diamond Growers, Borges Agricultural and…
WASHINGTON, March 17, 2024 /PRNewswire/ — In a significant advancement within the field of satellite communication technology, YTTEK is pleased to introduce the new product “Y.FORCE S” satellite modem. This ground station signal analysis and reception device, accompanied by Recorder and…
NEW YORK, March 17, 2024 /PRNewswire/ — The India – Baby Care Products Market is estimated to grow by USD 15.69 billion, accelerating at a CAGR of 17.31%, during the forecast period. The baby care products market in India is fragmented owing to the presence of many global and regional…
SHANGHAI, March 17, 2024 /PRNewswire/ — Everest Medicines (HKEX: 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has…
ZYMFENTRA™ is the first FDA-approved subcutaneous infliximab for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease ZYMFENTRA™ is commercially available across the U.S. on March 15, 2024 JERSEY CITY, N.J., March 17, 2024…
SINGAPOUR, 18 mars 2024 /PRNewswire/ — Mediwave, une entreprise de pointe dans le domaine des technologies de la santé, a été reconnue comme finaliste lors des prestigieux Global Mobile Awards (GLOMO), dans le cadre du Mobile World Congress (MWC) organisé par la GSMA à Barcelone, en…